Mattsson C - Search Results

1

Cognitive-behavioural stress management does not improve biological cardiovascular risk indicators in women with ischaemic heart disease: a randomized-controlled trial.

Claesson M, Birgander LS, Jansson JH, Lindahl B, Burell G, Asplund K, Mattsson C. Claesson M, et al. Among authors: mattsson c. J Intern Med. 2006 Oct;260(4):320-31. doi: 10.1111/j.1365-2796.2006.01691.x. J Intern Med. 2006. PMID: 16961669 Free article. Clinical Trial.

2

Elimination of native and carbohydrate-modified tissue plasminogen activator in rabbits.

Einarsson M, Hggroth L, Mattsson C. Einarsson M, et al. Among authors: mattsson c. Thromb Haemost. 1989 Dec 29;62(4):1088-93. Thromb Haemost. 1989. PMID: 2515604

3

Inhibition of carboxypeptidase U (TAFIa) activity improves rt-PA induced thrombolysis in a dog model of coronary artery thrombosis.

Björkman JA, Abrahamsson TI, Nerme VK, Mattsson CJ. Björkman JA, et al. Thromb Res. 2005;116(6):519-24. doi: 10.1016/j.thromres.2005.02.009. Epub 2005 Mar 17. Thromb Res. 2005. PMID: 16181987

4

Mechanism of action of the oral direct thrombin inhibitor ximelagatran.

Mattsson C, Sarich TC, Carlsson SC. Mattsson C, et al. Semin Vasc Med. 2005 Aug;5(3):235-44. doi: 10.1055/s-2005-916162. Semin Vasc Med. 2005. PMID: 16123910 Review.

5

Coronary thrombosis/thrombolysis in pigs: effects of heparin, ASA, and the thrombin inhibitor inogatran.

Uriuda Y, Wang QD, Hatori N, Nordlander R, Sjöquist PO, Mattsson C, Rydén L. Uriuda Y, et al. Among authors: mattsson c. J Pharmacol Toxicol Methods. 1998 Mar;39(2):81-9. doi: 10.1016/s1056-8719(98)00006-9. J Pharmacol Toxicol Methods. 1998. PMID: 9694166

6

Pharmacokinetics of heparin and low molecular weight heparin fragment (Fragmin) in rabbits with impaired renal or metabolic clearance.

Palm M, Mattsson C. Palm M, et al. Among authors: mattsson c. Thromb Haemost. 1987 Oct 28;58(3):932-5. Thromb Haemost. 1987. PMID: 2829379

7

Effect on haemostasis of intravenous injection of alpha 2-antiplasmin in cats treated with streptokinase.

Einarsson M, Mattsson C, Nilsson S. Einarsson M, et al. Among authors: mattsson c. Thromb Res. 1983 May 1;30(3):205-12. doi: 10.1016/0049-3848(83)90073-7. Thromb Res. 1983. PMID: 6868022

8

Bleeding times in rats treated with heparin, heparin fragments of high and low anticoagulant activity and chemically modified heparin fragments of low anticoagulant activity.

Palm M, Mattsson C, Svahn CM, Weber M. Palm M, et al. Among authors: mattsson c. Thromb Haemost. 1990 Aug 13;64(1):127-32. Thromb Haemost. 1990. PMID: 2177229

9

Effects of melagatran, a novel direct thrombin inhibitor, during experimental septic shock.

Eriksson M, Basu S, Larsson A, Mattsson C, Eriksson O, Kiiski R, Nordgren A. Eriksson M, et al. Among authors: mattsson c. Expert Opin Investig Drugs. 2000 May;9(5):1129-37. doi: 10.1517/13543784.9.5.1129. Expert Opin Investig Drugs. 2000. PMID: 11060733 Review.

10

Local proCPU (TAFI) activation during thrombolytic treatment in a dog model of coronary artery thrombosis can be inhibited with a direct, small molecule thrombin inhibitor (melagatran).

Mattsson C, Björkman JA, Abrahamsson T, Nerme V, Schatteman K, Leurs J, Scharpé S, Hendriks D. Mattsson C, et al. Thromb Haemost. 2002 Apr;87(4):557-62. Thromb Haemost. 2002. PMID: 12008935

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

152 results

Search Page

Filters